Price of Gold Fundamental Daily Forecast – Choppy as Omicron Impact Dims Correlation with Yields – Yahoo Finance

Science & Technology

Gold futures are under pressure on Monday on relatively low volume as traders return from the long Christmas weekend. However, we’re not expecting much of an uptick in the volume as we head into this weekend’s New Year holiday.
Thin trading conditions can lead to two scenarios:  tight trading ranges or exaggerated breakouts that fail. Both make trading difficult especially if there isn’t a major fundamental event driving the price action.
At 10:25 GMT, February Comex gold futures are trading $1805.80, down $5.90 or -0.33%. Last Thursday, the SPDR Gold Shares ETF (GLD) settled at $168.98, up $0.39 or +0.23%.
The two fundamentals in the spotlight today are U.S. Treasury yields and the U.S. Dollar.
Benchmark U.S. Treasury yields are edging higher, increasing the opportunity cost of holding bullion, which pays no interest. The U.S. Dollar Index is also edging higher, up from its weakest level in nearly a week, making dollar-denominated gold less-attractive to foreign buyers.
Last week, gold prices rose on increased demand for higher risk assets. Did gold suddenly become a higher risk asset? The answer is no.
An easing of tensions over Omicron led to the increased demand for higher yielding assets. In doing so, investors sold the safe-haven Treasurys, driving up yields. But we just told you that higher yields tend to weigh on non-yielding gold. So this move was likely ignored by gold traders.
But, investors also liquidated safe-haven positions in the U.S. Dollar. The greenback fell even though yields rose. However, the weaker dollar was probably the reason for the increased demand for gold.
Got it? At times like these when risk sentiment and safe-haven buys and sells are involved, you can throw out all of the correlation studies. They just don’t work especially when volume is below average.
The problem is the Omicron coronavirus variant causing this disjointed trading activity is not likely to go away with Dr. Fauci, the U.S. infectious disease expert, saying conditions could worsen – meaning the number of cases is expected to keep rising. This could mean more safe-haven buying of Treasurys and the U.S. Dollar, and more liquidation of these assets when the Omicron numbers retreat.
So what can you do as a trader? When you don’t expect to see a trend develop in either direction, you have to be willing to sell rallies into resistance and buy breaks into support until conditions create a strong opportunity for a trend to develop.
The daily chart identifies resistance as $1817.50 to $1832.70. The key support is $1784.40 to $1777.00.
Essentially, if Omicron becomes enough of an issue to dim risk sentiment, then look for yields to fall and the dollar to rise as traders seek safe-haven protection. This could weigh on gold prices.
If Omicron becomes less of an issue then look for risk sentiment to rise. This would lead to safe-haven dollar liquidation and higher gold prices.
For a look at all of today’s economic events, check out our economic calendar.

This article was originally posted on FX Empire
Vitalik Buterin Speaks On Ethereum and Its Future In Argentina
ROSE Rallies as Oasis Protocol’s Community Grows Stronger
Big Money Loves Paychex
Mexican Billionaire Ricardo Salinas Pliego Urges People to Buy Bitcoin
Are Bitcoin Payment Services Similar to Credit Cards? What’s the Difference?
GBP/USD Price Forecast – British Pound Continues to Hover Around 50 Day EMA
Oasis Protocol has reached 100,000 followers on Twitter, with its native coin, ROSE, rising by more than 8% in the past 24 hours.
The direction of the AUD/USD on Monday is likely to be determined by trader reaction to .7212.
Gold on Monday halts a string of gains at three consecutive sessions but manages to hold above the psychologically significant price at $1,800 an ounce.
Does the December share price for Pan American Silver Corp. ( TSE:PAAS ) reflect what it's really worth? Today, we will…
Silver markets initially fell during the trading session on Monday but then turned around to show signs of life again. Because of this, we are now threatening the 50 day EMA.
What happened Shares of Novavax (NASDAQ: NVAX) were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline? Other vaccine stocks aren't falling nearly as much.
After revealing a new sedan last week, rumors are swirling around the EV maker's next big announcement.
Semiconductor giant Advanced Micro Devices (NASDAQ: AMD) stock is up a solid 5.7% as of 2:05 p.m. ET Monday — the first trading day after the Christmas break. All year long, companies that build things that need semiconductors to run them — which, at this point in history, means everything from PCs to cellphones to cars to kids' toys — have struggled to get enough semiconductors to manufacture all the products that their customers want to buy. On the one hand, constrained chip supplies mean semiconductor makers can charge more money for their chips — but only if they have enough manufacturing capacity to make those chips in the first place.
The Santa Claus rally is off to the best start in over 20 years and historically that bodes well for the entire seasonal period, Dow Jones data show.
Innovation stocks have entered “deep value territory,” Wood says.
Apple (NASDAQ: AAPL) shareholders beat the market on Monday as the stock rose 2% by 3:30 p.m. ET compared with a 1% rise in the S&P 500. Apple stock participated in a rally for tech giants that included well-known growth names like Meta Platforms, Nvidia, and Tesla, which all beat the market on Monday. The tech-heavy Nasdaq index was up 1.2% by late Monday compared with a 1.1% boost in the S&P 500.
Navellier & Associates Founder & Chief Investment Officer Louis Navellier joins Yahoo Finance Live to discuss the low volume market rally in the final trading week of 2021 and which stocks could be attractive in 2022.
These last few weeks of 2021 have seen increased market volatility. Along with Omicron fears, the market fluctuations have come just as Wall Street is digesting the fact of a new Fed policy in the New Year, including the tightening up of monetary policy and at least one, probably more, interest rate hikes. The Fed’s easy money has been supportive for the better part of the past decade or more, and investors are rightly wondering how the market will adapt. Looking ahead, Wedbush’s Daniel Ives is
Dow Jones futures were little changed Monday after the stock market rally hit new highs. Tesla stock briefly topped a new buy point.
On Dec. 16, high-end electric pickup and SUV maker Rivian Automotive (NASDAQ: RIVN) reported its first-ever quarterly results since going public through its recent IPO. The company delivered 11 electric vehicles (EVs) in total during the third quarter of 2021, bringing in approximately $1 million in revenue. Meanwhile, its market capitalization (market cap) was a princely $100 billion at the time of the quarterly release.
China's BYD will look to top the 100,000 vehicles mark, after setting a sixth monthly EV sales record. Nio stock rose.
The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.
'Rich Dad Poor Dad' is as bearish as ever.
Two blue-chip value stocks, a growth at reasonable price stock, a growth stock with upside potential, and a COVID-19 pandemic play make up a list of five stocks to buy for 2022.
If you have $100 at the ready not needed for bills or emergencies and a brokerage that allows fractional share purchases, you have enough to buy into the following pair of no-brainer stocks right now. Palantir Technologies (NYSE: PLTR) is the Liam Neeson of data analytics stocks: It has a very particular set of skills that were acquired over a very long career. The U.S. military is also a prime customer, using Palantir's technology to coordinate millions of troops around the world.